Global Tumour Ablation Market, By
Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation,
HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By
Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By
End-User (Hospitals, Oncology Clinics, Others), By Geography (North America,
South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast
to 2024
The global tumour ablation market
has accounted for USD 1.8 billion in 2016, expected to reach USD 3.5 billion by
2024, growing at a CAGR of 8.2% in the forecast period 2017 to 2024.
Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample?dbmr=global-tumour-ablation-market
The global
tumour ablation market is expected to grow, owing to factors such as rising
cancer incidence, increased focus on treatment of breast cancer, better
reimbursement scenarios, shift towards value based reimbursements and
continuous development in ablation technology. The ablation technology has an
upper edge on chemotherapy and other oncology therapeutics. However ablation
technology can only be used to treat tumours with size less than 3cm, owing to
the healthy tissue damage caused by it. With the advent of guidance mechanisms
such as ultrasounds and MRI the accuracy of the treatment has increased
significantly in the past 5 years.
The global
tumour ablation market is segmented based on product types, cancer types,
end-user and geography.
The global tumour ablation market is
segmented into 3 type’s ablation systems, image guidance products and
accessories. The ablation systems dominates the market and is further segmented
based on product type into microwave ablation (coretherm thermotherapy devices
and prolieve thermotherapy devices), radiofrequency ablation (RFA)
((temperature controlled devices, fluid cooled, catheter manipulation systems),
high intensity focused ultrasound (HIFU), laser ablation and cryoablation. All
ablation techniques are percutaneous except HIFU which is administered
transcutaneously.
On the
basis of cancer types treated using ablation devices the market is segmented
into liver, lings, kidney, brain, bone, pancreas, breast and, other cancer
types.
Based on
end-user the global tumour ablation market is segmented into hospitals,
oncology clinics and others.
Inquiry
before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying?dbmr=global-tumour-ablation-market
Based on geography the Global Tumour Ablation Market is
segmented into:
·
North America
·
South America
·
Europe
·
Asia-Pacific
·
Rest of the World
Browse Full Report Visit @ http://databridgemarketresearch.com/reports/medical-devices/ablation-devices-medical-devices/global-tumour-ablation-market
The tumour ablation market’s major players have used
various strategies such as new product launches, expansions, agreements, joint
ventures, partnerships, acquisitions, and others to increase their footprints
in this market. Some examples of recent strategies/developments are: On
January, 2016 Medtronic acquired OsteoCool RF Ablation System from Baylis
Medical and received its FDA approval, December, 2015 DFINE, Inc. launched Long
SpineStar ablation system, January 2015, Medtronic acquired Covidien to
strengthen its leadership in medical devices industry among others. The report
includes market shares of tumour ablation market for global, Europe, North
America, Asia Pacific and Rest of the World.
Some of the major companies operating in this market are:
·
Galil Medical, Inc.
·
Perseon Corporation
·
NeuWave Medical, Inc.
·
Koninklijke Philips N.V.
·
INTIO Inc.
·
Mermaid Medical A/S
·
SonaCare Medical
·
LLC
·
DFINE, Inc.
·
Misonix, Inc.
·
BVM Medical Limited
·
AngioDynamics, Inc.
·
COMSOL Inc.
·
Boston Scientific Corporation
·
EDAP TMS S.A.
·
HealthTronics, Inc.
Table
of Content:
1.
INTRODUCTION
1.1. OVERVIEW OF THE TUMOUR ABLATION
MARKET
1.2. MARKET SEGMENTATION & COVERAGE
2.
RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE TUMOUR ABLATION
MARKET SIZE
2.2.1. MARKET CRACKDOWN
APPROACH
2.2.2. COMPANY REVENUE
AND MARKET SHARE ANALYSIS
2.2.3. DATA
TRIANGULATION
2.2.4. KEY DATA POINTS
FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS
FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE
FORCES MATRIX
2.2.7. PEST ANALYSIS
2.2.8. EPIDEMIOLOGY
FORECASTING MODELS
2.3. ASSUMPTIONS
3.
MARKET LANDSCAPE SUMMARY
4.
MARKET OVERVIEW
4.1. OVERVIEW
4.2. TUMOUR ABLATION MARKET: KEY PRIMARY
INSIGHTS
4.3. DRIVERS, OPPORTUNITIES AND THREAT
ANALYSIS MATRIX
4.4. KEY MARKET FINDINGS
4.5. KEY MARKET TRENDS AND UPCOMING
TECHNOLOGIES
5.
TUMOUR ABLATION MARKET, BY TYPE
5.1. OVERVIEW
5.2. TUMOUR ABLATION SYSTEMS
5.2.1. RADIO FREQUENCY ABLATION SYSTEM (RFA)
5.2.2. MICROWAVE ABLATION SYSTEM
5.2.3. HIGH FREQUENCY FOCUSED ULTRASOUND
ABLATION SYSTEM (HIFU)
5.2.4. LASER ABLATION SYSTEM
5.2.5. CRYOABLATION
5.3. IMAGE GUIDANCE PRODUCTS
5.4. ACCESSORIES
6.
TUMOUR ABLATION MARKET, BY CANCER TYPE
6.1. OVERVIEW
6.2. LIVER CANCER
6.3. BRAIN CANCER
6.4. LUNG CANCER
6.5. BONE CANCER
6.6. KIDNEY CANCER
6.7. PANCREATIC CANCER
6.8. BREAST CANCER
6.9. OTHERS
7.
TUMOR ABLATION MARKET, BY END-USER
7.1.
OVERVIEW
7.2.
HOSPITALS
7.3.
ONCOLOGY CLINICS
7.4.
OTHERS
8.
TUMOUR ABLATION MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE TUMOUR ABLATION
MARKET, (ALL SEGMENTATION PROVIDED ABOVE
IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
8.1.1. NORTH AMERICA
8.1.1.1. U.S.
8.1.1.2. CANADA
8.1.1.3. MEXICO
8.1.2. EUROPE
8.1.2.1. GERMANY
8.1.2.2. FRANCE
8.1.2.3. U.K.
8.1.2.4. ITALY
8.1.2.5. SPAIN
8.1.2.6. RUSSIA
8.1.2.7. TURKEY
8.1.2.8. BELGIUM
8.1.2.9. NETHERLANDS
8.1.2.10. SWITZERLAND
8.1.2.11. REST OF EUROPE
8.1.3. ASIA-PACIFIC (APAC)
8.1.3.1. JAPAN
8.1.3.2. CHINA
8.1.3.3. SOUTH KOREA
8.1.3.4. INDIA
8.1.3.5. AUSTRALIA
8.1.3.6. SINGAPORE
8.1.3.7. THAILAND
8.1.3.8. MALAYSIA
8.1.3.9. REST OF APAC
8.1.4. LATIN AMERICA
8.1.4.1. BRAZIL
8.1.4.2. REST OF LATIN AMERICA
8.1.5. REST OF THE WORLD
8.2. KEY PRIMARY INSIGHTS: BY MAJOR
COUNTRIES
9.
TUMOUR ABLATION MARKET: COMPETITIVE LANDSCAPE
9.1. GLOBAL TUMOUR ABLATION MARKET:
COMPANY SHARE ANALYSIS
9.2. NORTH AMERICA TUMOUR ABLATION
MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE TUMOUR ABLATION MARKET:
COMPANY SHARE ANALYSIS
9.4. APAC TUMOUR ABLATION MARKET:
COMPANY SHARE ANALYSIS
9.5. MERGERS & ACQUISITIONS
9.6. NEW PRODUCT DEVELOPMENT &
APPROVALS
9.7. EXPANSIONS
9.8. REGULATORY CHANGES
9.9. PARTNERSHIP AND OTHER STRATEGIC
DEVELOPMENTS
10.
TUMOUR ABLATION MARKET, COMPANY PROFILES
10.1. MEDTRONIC
10.1.1 OVERVIEW
10.1.2 SWOT ANALYSIS
10.1.3 PRODUCT PORTFOLIO
10.1.4 REVENUE ANALYSIS
10.1.5 ANALYSTS VIEW
10.2. GALIL MEDICAL, INC.
10.2.1 OVERVIEW
10.2.2 SWOT ANALYSIS
10.2.3 PRODUCT PORTFOLIO
10.2.4 REVENUE ANALYSIS
10.2.5 ANALYSTS VIEW
10.3
PERSEON CORPORATION
10.3.1 OVERVIEW
10.3.2 SWOT ANALYSIS
10.3.3 PRODUCT PORTFOLIO
10.3.4 REVENUE ANALYSIS
10.3.5 ANALYST VIEW
10.4
NEUWAVE MEDICAL, INC.
10.4.1 OVERVIEW
10.4.2 SWOT ANALYSIS
10.4.3 PRODUCT PORTFOLIO
10.4.4 REVENUE ANALYSIS
10.4.5 ANALYSTS VIEW
10.5. KONINKLIJKE PHILIPS N.V.
10.5.1 OVERVIEW
10.5.2 SWOT ANALYSIS
10.5.3 PRODUCT PORTFOLIO
10.5.4 REVENUE ANALYSIS
10.5.5
ANALYSTS VIEW
10.6. INTIO INC.
10.6.1 OVERVIEW
10.6.2 SWOT ANALYSIS
10.6.3 PRODUCT PORTFOLIO
10.6.4 REVENUE ANALYSIS
10.6.5 ANALYSTS VIEW
10.7. MERMAID MEDICAL A/S
10.7.1 OVERVIEW
10.7.2 SWOT ANALYSIS
10.7.3 PRODUCT PORTFOLIO
10.7.4 REVENUE ANALYSIS
10.7.5 ANALYSTS VIEW
10.8. SONACARE MEDICAL, LLC
10.8.1 OVERVIEW
10.8.2 SWOT ANALYSIS
10.8.3 PRODUCT PORTFOLIO
10.8.4 REVENUE ANALYSIS
10.8.5 ANALYSTS VIEW
10.9. DFINE, INC.
10.9.1. OVERVIEW
10.9.2. SWOT ANALYSIS
10.9.3. PRODUCT PORTFOLIO
10.9.4. REVENUE ANALYSIS
10.9.5. ANALYSTS VIEW
10.10. MISONIX, INC.
10.10.1. OVERVIEW
10.10.2. SWOT ANALYSIS
10.10.3. PRODUCT PORTFOLIO
10.10.4. REVENUE ANALYSIS
10.10.5. ANALYSTS VIEW
10.11. BVM MEDICAL LIMITED
10.11.1. OVERVIEW
10.11.2. SWOT ANALYSIS
10.11.3. PRODUCT PORTFOLIO
10.11.4. REVENUE ANALYSIS
10.11.5. ANALYSTS VIEW
10.12. ANGIODYNAMICS, INC.
10.12.1. OVERVIEW
10.12.2. SWOT ANALYSIS
10.12.3. PRODUCT PORTFOLIO
10.12.4. REVENUE ANALYSIS
10.12.5. ANALYSTS VIEW
10.13. COMSOL INC.
10.13.1. OVERVIEW
10.13.2. SWOT ANALYSIS
10.13.3. PRODUCT PORTFOLIO
10.13.4. REVENUE ANALYSIS
10.13.5. ANALYSTS VIEW
10.14. BOSTON SCIENTIFIC CORPORATION
10.14.1. OVERVIEW
10.14.2. SWOT ANALYSIS
10.14.3. PRODUCT PORTFOLIO
10.14.4. REVENUE ANALYSIS
10.14.5. ANALYSTS VIEW
10.15. EDAP TMS S.A.
10.10.1. OVERVIEW
10.10.2. SWOT ANALYSIS
10.10.3. PRODUCT PORTFOLIO
10.10.4. REVENUE ANALYSIS
10.10.5. ANALYSTS VIEW
10.16. HEALTHTRONICS, INC.
10.11.1. OVERVIEW
10.11.2. SWOT ANALYSIS
10.11.3. PRODUCT PORTFOLIO
10.11.4. REVENUE ANALYSIS
10.11.5. ANALYSTS VIEW
11.
APPENDIX
11.1. RELATED REPORTS
11.2. CUSTOMIZABLE OPTIONS
11.3. SOURCE SHEET
11.4. BIBLIOGRAPHY
Related
Report
Global
Infection Control Market – Trends and Forecast to 2024
Global Infection Control Market, By
Type (Disinfection (Medical Nonwovens, Disinfectants, Disinfectors (Washer,
Flusher, U.V. Rays), Disinfectant Wipes, Endoscope Reprocessors), Sterilization
(Products (Heat, Low Temperature, Radiation, Filtration), Services)), By
Application, By End-User (Hospitals, Medical Device Manufacturers,
Pharmaceutical Manufacturers, Food and Beverage Industry, Laboratory), By
Geography (North America, Europe, Asia-Pacific, South America, Middle East and
Africa) – Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric Market
research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Ankit Singh
Data Bridge
Market Research
Tel:
+1-888-387-2818
Investor: investors@databridgemarketresearch.com